Clinical Trial Update: Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring zinc as an enhancer of immune recovery after stem cell transplantation for hematological malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancies
• Stem Cell Transplantation Complications

Drugs mentioned

• ZINC (Zinc chloride)

Snippet

Sponsor: Azienda Ospedaliero, Universitaria Pisana | Conditions: Stem Cell Transplant Complications | Phase 2 | Status: COMPLETED